All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection (Q42238837)
Jump to navigation
Jump to search
scientific article published on 28 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection |
scientific article published on 28 May 2014 |
Statements
1 reference
All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection (English)
1 reference
Stanislas Pol
1 reference
David L Wyles
1 reference
Mark S Sulkowski
1 reference
Diana M Brainard
1 reference
John G McHutchison
1 reference
François Habersetzer
1 reference
Maribel Rodriguez-Torres
1 reference
Eric Lawitz
1 reference
Yanni Zhu
1 reference
Mitchell L Shiffman
1 reference
Robert W Herring
1 reference
Benedetta Massetto
1 reference
Bittoo Kanwar
1 reference
James D Trenkle
1 reference
Phil S Pang
1 reference
Hongmei Mo
1 reference
G Mani Subramanian
1 reference
28 May 2014
1 reference
1 reference
60
1 reference
1
1 reference
56-64
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference